The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
From fiscal year 2007 to 2009, the US Food and Drug Administration increased the number of foreign drug inspections it conducted, but the agency still conducted fewer foreign inspections than domestic inspections each year, according to a recent report by the US Government Accountability Office (GAO).
Editors' picks of pharmaceutical science and technology innovations.
Abuse-deterrent combination drugs represent a niche area in formulation development.
USP is working to ensure quality standards and to increase public information.
A recent book offers an excellent overview of cleaning validation.
IP rights and levels of innovation have opened a bit of controversy regarding decisions being made by Indian courts and legislators.
An analysis of the approaches and tools used to tackle the problem of poorly soluble drugs.
A conversation with Mike de la Montaigne, president of Eisai Machinery, USA Inc., about the possibilities for conducting fully automated product inspections.
As technology advances, industry's needs are growing.
Scientists and practitioners must work together for the overall good of the patient.
A new center may provide evidence for improving care, but could discourage coverage of treatments.
The authors describe the development of an inclusion complex of GLZ and formulated an extended-release dosage form based on osmotic technology.
Remaining calm, cool, and collected during mergers and inspections is a feat in itself.
The authors demonstrated that ODTs can be obtained by direct compression of a mixture of starch, fructose, and SMCC.
Post recession and beyond, which contract service providers will still be standing?
Connecting science and policy might increase support for innovation.
Used packaging equipment can be a cost-saving, time-saving alternative to new machines.
Stuart Needleman, president of active-ingredient development and manufacturing at Aptuit, discusses industry trends and challenges.
The author reviews key considerations for formulating powders for use in inhalers. This article is part of a special Drug Delivery issue.
Product integrity issues in the global pharma market are a hot topic at the moment and many companies are reviewing and increasing their quality control procedures.
The authors describe an alternative approach to compressing and coating minitablets for use in a sustained-release, solid oral-dosage form. This article is part of a special Drug Delivery issue.
The author outlines how to choose carriers and capsule shells according to dosage requirements and intended use. This article is part of a special Drug Delivery issue.
Robots are becoming faster, cheaper and smaller. In pharmaceutical packaging applications, robots are often used at the end of the process — either in the primary packing of product into small packs, or further downstream product packing into cartons and subsequent palletising.
The author reviews advances in technology that may soon allow transdermal delivery of two of the fastest growing drug classes on the pharmaceutical market. This article is part of a special Drug Delivery issue.
Leading European experts from the pharmaceutical packaging industry explain how they are coping with industry trends.